rs749956849
Positions:
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PVS1PP5_Very_Strong
The NM_000416.3(IFNGR1):c.523delT(p.Tyr175fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000204 in 1,613,724 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000021 ( 0 hom. )
Consequence
IFNGR1
NM_000416.3 frameshift
NM_000416.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: -0.383
Genes affected
IFNGR1 (HGNC:5439): (interferon gamma receptor 1) This gene (IFNGR1) encodes the ligand-binding chain (alpha) of the gamma interferon receptor. Human interferon-gamma receptor is a heterodimer of IFNGR1 and IFNGR2. A genetic variation in IFNGR1 is associated with susceptibility to Helicobacter pylori infection. In addition, defects in IFNGR1 are a cause of mendelian susceptibility to mycobacterial disease, also known as familial disseminated atypical mycobacterial infection. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 16 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PP5
Variant 6-137204354-TA-T is Pathogenic according to our data. Variant chr6-137204354-TA-T is described in ClinVar as [Pathogenic]. Clinvar id is 208588.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr6-137204354-TA-T is described in Lovd as [Pathogenic]. Variant chr6-137204354-TA-T is described in Lovd as [Pathogenic]. Variant chr6-137204354-TA-T is described in Lovd as [Likely_pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IFNGR1 | NM_000416.3 | c.523delT | p.Tyr175fs | frameshift_variant | 4/7 | ENST00000367739.9 | NP_000407.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
2
AN:
152208
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000159 AC: 4AN: 251312Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135824
GnomAD3 exomes
AF:
AC:
4
AN:
251312
Hom.:
AF XY:
AC XY:
4
AN XY:
135824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000212 AC: 31AN: 1461516Hom.: 0 Cov.: 31 AF XY: 0.0000206 AC XY: 15AN XY: 727102
GnomAD4 exome
AF:
AC:
31
AN:
1461516
Hom.:
Cov.:
31
AF XY:
AC XY:
15
AN XY:
727102
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152208Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74368
GnomAD4 genome
AF:
AC:
2
AN:
152208
Hom.:
Cov.:
32
AF XY:
AC XY:
0
AN XY:
74368
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Department of Pathology and Laboratory Medicine, Sinai Health System | - | The IFNGR1 p.Y175Mfs*2 variant has been reported as a homozygous or compound heterozygous variant in 6 cases of mycobacterial infection susceptibility due to interferon gamma receptor deficiency (Khanolkar_2018_ PMID: 28927822; Olbrich_2015_PMID:26173802; Koscielniak_2003_PMID:12712974; Dorman_2004_PMID:15589309; Marazzi_2009_PMID:19880337). The variant was identified in dbSNP (ID: rs749956849) and ClinVar (classified as pathogenic by Invitae and Laboratory for Molecular Medicine). The variant was identified in control databases in 4 of 251312 chromosomes at a frequency of 0.00001592 (Genome Aggregation Database March 6, 2019, v2.1.1). The variant was observed in the European (non-Finnish) population in 4 of 113632 chromosomes (freq: 0.000035), but was not observed in the African, Latino, Ashkenazi Jewish, East Asian, European (Finnish), Other, or South Asian populations. The c.523del variant is predicted to cause a frameshift, which alters the protein's amino acid sequence beginning at codon 175 and leads to a premature stop codon 2 codons downstream. This alteration is then predicted to result in a truncated or absent protein and loss of function. Loss of function variants of the IFNGR1 gene are an established mechanism of disease in mycobacteriosis immunodeficiency and is the type of variant expected to cause the disorder. Further, functional data from a patient homozygous for this variant demonstrated a lack of interferon gamma receptor expression at the cell surface (Koscielniak_2003_PMID:12712974). In summary, based on the above information this variant meets our laboratory’s criteria to be classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Revvity Omics, Revvity | Oct 01, 2019 | - - |
Disseminated atypical mycobacterial infection Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 29, 2023 | For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 208588). This premature translational stop signal has been observed in individual(s) with Mendelian susceptibility to mycobacterial disease (MSMD) due to interferon-gamma receptor 1 deficiency (PMID: 15589309, 19880337, 25216720). This variant is present in population databases (rs749956849, gnomAD 0.003%). This sequence change creates a premature translational stop signal (p.Tyr175Metfs*2) in the IFNGR1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IFNGR1 are known to be pathogenic (PMID: 8960473, 9806040). - |
Inherited Immunodeficiency Diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | research | NIHR Bioresource Rare Diseases, University of Cambridge | Jan 01, 2019 | - - |
Immunodeficiency 27A Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine | Oct 07, 2014 | The p.Tyr175MetfsX2 variant in IFNGR1 has been reported in 4 homozygous individuals with IFNGR1 deficiency (Koscielnak 2003, Dorman 2004, Marazzi 2010) and was absent from large population studies. This variant is predicted to cause a frameshift, which alters the protein’s amino acid sequence beginning at position 175 and leads to a premature termination codon 2 amino acids downstream. This alteration is then predicted to lead to a truncated or absent protein. In vivo functional studies indicate this variant results in the absence of surface IFNGR1 expression and diminished cellular response to interferon gamma (Koscielnak 2003). In summary, this variant meets our criteria to be classified as pathogenic for IFNGR1 deficiency in an autosomal recessive manner (http://personalizedmedicine.partners.org/Laboratory-For-Molecular-Medicine/) due to the predicted impact to the protein and functional data. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at